Melatonin Neurim

Melatonin, the active ingredient in Melatonin Neurim, is a melatonin receptor agonist presented as an oral formulation for oral use. It helps regulate the sleep‑wake cycle and is used to manage insomnia and jet‑lag symptoms in adults. The compound mimics the endogenous hormone melatonin, binding to MT1 and MT2 receptors in the suprachiasmatic nucleus to promote sleep onset and improve circadian alignment.

GNH USA supplies Melatonin Neurim as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Melatonin Neurim acts on the melatonin pathway to support normal sleep regulation. - Insomnia: facilitates faster sleep onset and improves sleep quality in individuals who have difficulty falling asleep. - Jet lag: helps synchronize the circadian rhythm after rapid travel across time zones, reducing daytime fatigue. - Circadian rhythm sleep disorders: assists in adjusting abnormal sleep‑wake patterns such as shift‑work disorder, promoting a more regular sleep schedule.

Melatonin Neurim may cause a range of adverse reactions.

Common Side Effects: - Headache: mild to moderate pain often occurring after the first dose. - Dizziness: transient sensation of light‑headedness, especially when standing quickly. - Daytime sleepiness: residual drowsiness that may affect alertness. - Nausea: mild stomach discomfort or queasiness. - Vivid dreams: unusually intense or memorable dreaming. - Mild gastrointestinal upset: occasional stomach cramps or loose stools.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Severe skin eruption: Stevens‑Johnson‑like rash requiring medical attention. - Mood changes: depression, anxiety, or irritability. - Hallucinations: visual or auditory disturbances. - Worsening of seizure disorders: increased seizure frequency in susceptible individuals.

When considering Melatonin Neurim, several safety measures should be observed. - Assess medical history: evaluate for underlying sleep disorders or psychiatric conditions before use. - Avoid use with alcohol: concurrent consumption may intensify sedation. - Monitor in elderly: older adults may experience greater daytime drowsiness and should start with the lowest effective dose. - Pregnancy and lactation: consult a healthcare professional before use, as safety data are limited. - Review drug interactions: check for concomitant medications that may alter melatonin levels. - Store at ambient temperature below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Melatonin Neurim can interact with other medicines, requiring attention to potential additive effects.

Major Interactions (Avoid): - CNS depressants (e.g., benzodiazepines, barbiturates): may cause excessive sedation. - Immunosuppressants (e.g., cyclosporine): melatonin may affect drug metabolism, reducing efficacy.

Moderate Interactions (Monitor Closely): - Antihypertensives: melatonin can modestly lower blood pressure, requiring blood pressure monitoring. - Oral contraceptives: may increase circulating melatonin levels, potentially altering hormonal balance. - Caffeine-containing products: can counteract melatonin’s sleep‑promoting effect, reducing efficacy.